Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

No evidence for shared genetic basis of common variants in multiple sclerosis and amyotrophic lateral sclerosis.
We know how to prescribe natalizumab for multiple sclerosis, but do we know how to withdraw it?
Risk Mitigation Strategies for Adverse Reactions Associated with the Disease-Modifying Drugs in Multiple Sclerosis.
L-periaxin interacts with S-periaxin through its PDZ domain.
Lipopolysaccharide from Rhodobacter sphaeroides Attenuates Microglia-Mediated Inflammation and Phagocytosis and Directs Regulatory T Cell Response.
Neuroinflammation and demyelination from the point of nitrosative stress as a new target for neuroprotection.
A single-nucleotide polymorphism in serine-threonine kinase 11, the gene encoding liver kinase b1, is a risk factor for multiple sclerosis.
Natalizumab to fingolimod: Questions answered, unanswered, and unasked.
Myeloid-derived suppressor cells in immunity and autoimmunity.
Epstein-Barr virus infection-Related hemophagocytic lymphohistiocytosis.
[Pulmonary lymphangioleiomyomatosis of unusual revelation during multiple sclerosis].
Pathologic and imaging correlates of cognitive deficits in multiple sclerosis: changing the paradigm of diagnosis and prognosis.
Functional electrical stimulation as a component of activity-based restorative therapy may preserve function in persons with multiple sclerosis.
Current Perspectives on Interferon Beta-1b for the Treatment of Multiple Sclerosis.
Leukocyte counts in cerebrospinal fluid and blood following firategrast treatment in subjects with relapsing forms of multiple sclerosis.
Therapies for multiple sclerosis: translational achievements and outstanding needs.
Multiple sclerosis increases the risk of infections resulting in a hospitalization among veterans.
MRI lesions: a surrogate for relapses in multiple sclerosis?
Association of interleukin (IL)-4 gene intron 3 VNTR polymorphism with multiple sclerosis in Turkish population.
Individual Face-to-Face Cognitive Behavioural Therapy in Multiple Sclerosis: A Qualitative Study.
Clinical Guidance of Community Physiotherapists Regarding People with MS: Professional Development and Continuity of Care.
Detection of clinical relapses in multiple sclerosis cohorts: construction and validation of a model based on administrative data.
Patterns and predictors of naturally occurring change in depressive symptoms over a 30-month period in multiple sclerosis.
Internal jugular veins out flow in patients with multiple sclerosis:a catheter venography study.
Restless legs syndrome as the initial presentation of multiple sclerosis.

Pages